Danaher Corporation (DHR)
| Market Cap | 148.95B |
| Revenue (ttm) | 24.57B |
| Net Income (ttm) | 3.61B |
| Shares Out | 707.14M |
| EPS (ttm) | 5.05 |
| PE Ratio | 41.88 |
| Forward PE | 25.05 |
| Dividend | $1.28 (0.61%) |
| Ex-Dividend Date | Mar 27, 2026 |
| Volume | 5,242,138 |
| Open | 208.01 |
| Previous Close | 209.36 |
| Day's Range | 206.88 - 210.68 |
| 52-Week Range | 171.00 - 242.80 |
| Beta | 0.96 |
| Analysts | Strong Buy |
| Price Target | 250.56 (+18.95%) |
| Earnings Date | Jan 28, 2026 |
About DHR
Danaher Corporation designs, manufactures, and markets professional, medical, research, and industrial products and services in the United States, China, and internationally. The company operates through Biotechnology, Life Sciences, and Diagnostics segments. The Biotechnology segment provides technologies, consumables, services, and solutions that advance, accelerate, and integrate the development and manufacture of therapeutics; cell line and cell culture media development services; cell culture media, process liquids and buffers for manufact... [Read more]
Financial Performance
In 2025, Danaher's revenue was $24.57 billion, an increase of 2.90% compared to the previous year's $23.88 billion. Earnings were $3.61 billion, a decrease of -7.31%.
Financial StatementsAnalyst Forecast
According to 16 analysts, the average rating for DHR stock is "Strong Buy." The 12-month stock price target is $250.56, which is an increase of 18.95% from the latest price.
News
Baron Durable Advantage Fund Q4 2025 Performance Review
During the fourth quarter, we initiated a new position in the leading energy-focused specialty contracting company, Quanta Services. Within the existing portfolio, our biggest addition during the quar...
Danaher Announces Quarterly Dividend
WASHINGTON, Feb. 24, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.40 per share of its common st...
Danaher to Present at TD Cowen Health Care Conference
WASHINGTON, Feb. 24, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the TD Cowen Healthcare Conferenc...
Harbor Large Cap Value Fund Q4 2025 Portfolio Review
During the fourth quarter, the Harbor Large Cap Value Fund returned 1.26%, underperforming its benchmark, the Russell 1000® Value Index, which returned 3.81%, and underperforming the 2.66% return of t...
Danaher to buy Masimo for $9.9 billion
Danaher will acquire pulse oximeter maker Masimo for $9.9 billion, the company said on Tuesday, as the contract research firm looks to bulk up its diagnostics portfolio.
Masimo to be Acquired by Danaher for $180.00 Per Share
IRVINE, Calif.--(BUSINESS WIRE)--Masimo Corporation (Nasdaq: MASI) (“Masimo”), a leading global medical innovator, today announced that it has entered into a definitive agreement pursuant to which Dan...
Danaher To Acquire Masimo Corporation
WASHINGTON, Feb. 17, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR), a global science and technology innovator, announced today that it has entered into a definitive agreement to acquire Masimo ...
Wall Street Breakfast Podcast: Masimo Jumps As Danaher Nears $10B Deal
Danaher (DHR) is nearing a ~$10B acquisition of Masimo (MASI), representing a significant premium to MASI's prior $7B market cap. Elliott Investment Management has built a >10% stake in Norwegian Crui...
Danaher Strikes $10 Billion Deal for Masimo
The medical-device maker is expected to operate as a stand-alone company within Danaher's Diagnostics segment.
Danaher closes in on nearly $10 billion deal for Masimo, FT reports
US healthcare manufacturer Danaher is closing in a nearly $10 billion deal to acquire medical technology company Masimo , the Financial Times reported on Monday, citing people familiar with the matter...
50% In Just 5 Stocks: Why I'm Willing To Invest Big In High-Quality
My concentrated portfolio emphasizes high-conviction holdings: LandBridge, Texas Pacific Land (TPL), QXO Inc., Old Dominion Freight Line (ODFL), and Carlisle Companies (CSL). I prioritize companies wi...
Halper Sadeh LLC Encourages Danaher Corporation Shareholders to Contact the Firm to Discuss Their Rights
Shareholders should contact the firm immediately as there may be limited time to enforce your rights. Shareholders should contact the firm immediately as there may be limited time to enforce your righ...
54 Stocks, 9 Megatrends: My Favorite Places To Be While Capital Is 'Forced'
My top-down strategy targets 'mission-critical' sectors where capital is forced by secular and cyclical tailwinds—data centers, energy, AI, defense, and infrastructure. AI-driven data center and energ...
Danaher Stock Plunge Does Not Represent A Good Entry Point
Danaher Stock Plunge Does Not Represent A Good Entry Point
Danaher Corporation (DHR) Q4 2025 Earnings Call Transcript
Danaher Corporation (DHR) Q4 2025 Earnings Call Transcript
Danaher Expects Gradual Improvement In End-Market Conditions
Danaher Corp (NYSE: DHR) on Wednesday reported fourth-quarter 2025 sales of $6.84 billion, up 4.5% year-over-year, beating the consensus of $6.81 billion.
Danaher forecasts 2026 profit in line with estimates on pharma spending recovery
Life sciences firm Danaher Corp forecast annual profit largely in line with Wall Street estimates on Wednesday and beat fourth-quarter profit and revenue expectations, as improving conditions in the p...
Danaher Reports Fourth Quarter and Full Year 2025 Results
WASHINGTON, Jan. 28, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) (the "Company") today announced results for the fourth quarter and full year 2025. All results in this release reflect only c...
Danaher Corporation (DHR) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Danaher Corporation (DHR) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript
Mar Vista U.S. Quality Q4 2025 Top Contributors And Detractors
Mar Vista's U.S. Quality strategy returned +0.20% net-of-fees in Q4 2025. The Russell 1000 Index and the S&P 500 Index returned +2.41% and +2.65%, respectively. Alphabet, Johnson & Johnson and Danaher...
Danaher CEO to Comment on Financial Performance
WASHINGTON, Jan. 12, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) (the "Company") announced that its President and Chief Executive Officer, Rainer M. Blair, will comment tomorrow on the Compan...
The Big 3: BA, DHR, DG
Dan Deming offers a glimpse into companies outside the AI trade he sees rallying in 2026. He offers bullish perspective and example options trades for Boeing (BA), Danaher (DHR), and Dollar General (D...
Danaher Is Ready to Put Its Post-Covid Malaise Behind It
With tariff rules finalized and inventories depleted, there's light at the end of the tunnel for the medical and scientific tools manufacturer.
Danaher to Present at J.P. Morgan Healthcare Conference
WASHINGTON, Jan. 5, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that its President and Chief Executive Officer, Rainer M. Blair, will be presenting at the J.P.
Top 15 High-Growth Dividend Stocks For January 2026
My Top 15 High-Growth Dividend Stock list delivered a 0.83% gain in December, outperforming SPY and VIG. The Value-tilted portfolio variant led with a 2.17% December return, suggesting undervaluation ...